| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 4.398 | 21.492 | 24.622 | 11.329 | 27.870 | 9.179 | 4.033 | 9.873 |
| Total Income - EUR | - | - | 5.687 | 21.492 | 24.622 | 11.343 | 27.870 | 9.179 | 4.034 | 9.873 |
| Total Expenses - EUR | - | - | 6.289 | 20.346 | 23.771 | 22.932 | 28.408 | 32.186 | 31.240 | 22.455 |
| Gross Profit/Loss - EUR | - | - | -602 | 1.147 | 851 | -11.590 | -538 | -23.006 | -27.207 | -12.582 |
| Net Profit/Loss - EUR | - | - | -646 | 932 | 605 | -11.667 | -667 | -23.144 | -27.207 | -12.582 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Oxytherapy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 23.781 | 47.934 | 36.572 | 25.642 | 81.994 | 65.545 | 54.146 | 42.705 |
| Current Assets | - | - | 1.017 | 1.124 | 3.965 | 2.180 | 13.705 | 8.640 | 201 | 4.776 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 220 | 0 | 0 | 2.713 |
| Cash | - | - | 1.017 | 1.124 | 3.965 | 2.180 | 13.485 | 8.640 | 201 | 2.063 |
| Shareholders Funds | - | - | -602 | 384 | 981 | -10.581 | -11.013 | -34.191 | -61.295 | -73.535 |
| Social Capital | - | - | 44 | 86 | 84 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | 25.400 | 48.675 | 39.556 | 38.552 | 106.791 | 108.436 | 115.764 | 121.035 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9604 - 9604" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Oxytherapy Srl